Research Projects

This database contains information on EU funded dementia research projects, undertaken since 2007. It is the product of a mapping exercise of European funding programmes for dementia research conducted by Alzheimer Europe in 2020. This database is not an exhaustive resource of information. It contains information about dementia research projects that are funded by European programmes including FP7, H2020, IMI, JPND, AAL and the third EU Health programme. The mapping exercise and database were expanded in 2025, to include projects funded under Horizon Europe (including IHI). For these projects, the database reports the maximum contribution from the European Commission rather than the total project budget, so funding figures may not be directly comparable across all entries.
For an overview of projects, Alzheimer Europe is involved in, visit: https://www.alzheimer-europe.org/our-work/current-work

Filters

(Clear all)

Brain Endothelium - TARgeted Gene therapy to improve Aβ clearance in Alzheimer’s Disease

BEndTarG

Alzheimer disease (AD) is the most common cause of dementia (60-80% of cases) with a prevalence near 50 million people. There is no cure available and there are only two classes of approved drugs that are effective in treat some of the cognitive symptoms and potentially delay the clinical decline. Despite the considerable progress achieved in the...

Funding Programme
Start Date
End Date
Total Funding
€ 165 312
European Countries Involved

Brain fluids - Transport and clearance

aCleanBrain

"Scientific breakthroughs in neuroscience explain the need for sleep and the development of neurodegenerative diseases such as Alzheimer's and Parkinson's diseases in terms of fluid dynamics: the waste created during the day is cleared away as we sleep or it accumulates. However, a decade of research after the original theory was posed has revealed...

Funding Programme
Start Date
End Date
Total Funding
€ 2 493 750
European Countries Involved

Brain health in Atherosclerosis and Cardiovascular risk in mid-life, a PESA-Brain project

BrainAtCardio

This project aims to investigate the early associations between cardiovascular health and Alzheimers disease (AD) pathology, with a focus on subclinical atherosclerosis (SCAth) and cardiovascular risk factors (CVRFs), in a large cohort of asymptomatic, middle-aged individuals. The overarching objective is to determine how cardiovascular health in...

Funding Programme
Start Date
End Date
Total Funding
€ 194 074
European Countries Involved

Cellular Strategies of Protein Quality Control-Degradation

CellularPQCD

Maintaining the quality of all proteins in an organism is fundamental to life since it ensures tissue function, organismal health, and longevity. Protein quality control (PQC) is achieved by selective degradation of damaged proteins, limiting the formation of protein aggregates and neurodegeneration characteristic of Alzheimers, Huntingtons, and...

Funding Programme
Start Date
End Date
Total Funding
€ 2 500 000
European Countries Involved

Center for Artificial Intelligence and Quantum Computing in System Brain Research

CLARA

CLARA, the Center for Artificial Intelligence and Quantum Computing in System Brain Research, represents the interdisciplinary center of excellence focused on the next generation of artificial intelligence/machine learning applications and quantum-centric supercomputing tools to push the frontier of neurodegeneration research, particularly...

Funding Programme
Start Date
End Date
Total Funding
€ 14 999 782
European Countries Involved

Characterization of the role of Sac1 in the spatiotemporally controlled interplay between PI4P and cholesterol homeostasis

PIP-AID

Lipids are essential components of cell membranes. Every organelle membrane is constituted of a unique composition of different lipid species. This distinctive lipid distribution along organelle membranes is important to maintain the identity and functions of the different organelles. In this research project, I aim to understand how the lipid...

Funding Programme
Start Date
End Date
Total Funding
€ 199 694
European Countries Involved

Circadian rhythm: from preclinical to post-diagnosis dementia

RHYTHM IN DEMENTIA

Circadian rhythm (CR) regulates body functions over the 24-hour day/night period; sleep/wake cycle is its most visible manifestation. CR disruptions have long been observed in patients with dementia and emerging evidence points to their presence in the preclinical period of dementia. This suggests that certain aspects of CR could be useful in...

Funding Programme
Start Date
End Date
Total Funding
€ 1 999 982
European Countries Involved

Closed-loop deep learning in early-stage drug discovery - cloud platform for targeted protein degradation

CelerisTx - Celeris One Platform

Celeris Therapeutics is a deep learning company that uses innovative, in-silico methods such as geometric deep learning and graph neural networks to degrade currently undruggable targets (pathogenic proteins). The platform shall make a broad impact by addressing currently incureable diseases such as Alzheimer's, Parkinson's, and different types of...

Funding Programme
Start Date
End Date
Total Funding
€ 2 500 000
European Countries Involved

Co-designing a Home with Dementia

HOMEDEM

The Doctoral Network “Co-designing a Home with Dementia” (HOMEDEM) is a Marie-Skłodowska-Curie Actions' Innovative Training Network that will provide high-level training in design and dementia caregiving, to high achieving, early-stage researchers. HOMEDEM focuses on the recent move across Europe towards supporting people with dementia (PwD) living...

Funding Programme
Start Date
End Date
Total Funding
€ 2 122 747
European Countries Involved

Cofactors at the core of tau prion behaviour

cofacTau

"Tau is an intrinsically disordered protein that regulates microtubule activity in neurons. Aggregation of tau into amyloid fibrils is diagnostic of several diseases, termed tauopathies, that include Alzheimer's disease. Distinct amyloid aggregate structures, so-called ""strains"", are involved in different tauopathies. These assemblies can spread...

Funding Programme
Start Date
End Date
Total Funding
€ 1 449 750
European Countries Involved

COMORBIDITY MECHANISMS UTILIZED IN HEALTHCARE

COMMUTE

The COVID pandemic can be seen as an experiment done with the entirety of humankind (as almost everybody has been or will get infected with SARS-CoV-2). It will therefore have the best coverage over the widest variation possible and is therefore ideally suited to study the effects of infections with SARS-CoV-2 on large quantities of heterogeneous...

Funding Programme
Start Date
End Date
Total Funding
€ 7 280 986

COnfident DEcisions

CODE

Virtually every decision people make comes with a sense of confidence – a subjective estimate of decision quality. The human capacity for confidence has tremendous social, clinical, and industrial impact. For example, children who can correctly judge their own level of confidence perform better academically. In the elderly, confidence declines...

Funding Programme
Start Date
End Date
Total Funding
€ 2 446 322
European Countries Involved
 
Acknowledgement
Alzheimer Europe's database on research projects was developed as part of the 2020 Work Plan which received funding under an operating grant from the European Union’s Health Programme (2014–2020).